Clinical Trials Directory

Trials / Terminated

TerminatedNCT01838863

Control of Major Bleeding After Trauma Study

A Prospective, Randomized Comparison of Fresh Frozen Plasma Versus Standard Crystalloid Intravenous Fluid as Initial Resuscitation Fluid

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
144 (actual)
Sponsor
Denver Health and Hospital Authority · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Bleeding is the most avoidable cause of death in trauma patients. Up to one-third of severely injured trauma patients are found to be coagulopathic and forty percent of the mortality following severe injury is due to uncontrollable hemorrhage in the setting of coagulopathy. It has been established that early administration of fresh frozen plasma decreases mortality following severe injury, replacing lost coagulation factors, improving the coagulopathy and restoring blood volume. This study will determine if giving plasma to severely injured trauma patients during ambulance transport versus after arrival to the hospital will help reduce hemorrhage, thus decreasing both total blood product administration and mortality.

Detailed description

Study Design: Severely injured trauma patients with a systolic blood pressure (SBP) ≤ 70 or SBP ≤ 90 with a heart rate ≥ 108 bpm at the scene will be enrolled and randomized to receive either 2 units of frozen plasma thawed in the field or normal saline (the current standard of care), as the initial resuscitation fluid. After this initial resuscitation fluid, both groups will receive the same standard of care, including packed red blood cells, additional normal saline, or plasma as needed based on laboratory and clinical evidence of coagulopathy. Blood samples and clinical information will be collected throughout the hospital stay up to 28 days after injury.

Conditions

Interventions

TypeNameDescription
BIOLOGICALType AB plasmaThe plasma is thawed and administered to subjects in the experimental (plasma) arm.
DRUGCrystalloid fluid (standard of care for resuscitation)Normal saline will be give to subjects in the standard arm as the current standard of care for an initial resuscitation fluid

Timeline

Start date
2014-04-07
Primary completion
2017-04-03
Completion
2017-04-03
First posted
2013-04-24
Last updated
2019-01-08
Results posted
2018-07-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01838863. Inclusion in this directory is not an endorsement.